Outcome, of treatment

Outcomes of treatment in primary care depend on a complex set of interactions between the treatment offered, the practice of health-care professionals, the behaviour of patients, and the system of health care in which the treatment is delivered. The practice of health-care professionals and the behaviour of patients may be influenced by culture and training. Even where cultural norms. 

Evaluate the clinical outcomes of treatment by using the UPDRS. In addition, periodically ask patients to record the amount of on and off time they have with and without dyskinesias in a diary. There are a variety of scales that can be used to assess QOL, depression, anxiety, and sleep disorders. Patients with PD cannot be cured but treatment can delay the progression of symptoms and improve QOL. Delaying the patient s admission into a nursing home is a good outcome. 

The major measure of outcome of treatment of SVCS is the relief of symptoms, regardless of the therapy used. SVC stenting provides rapid relief of symptoms within 1 to 7 days of stent placement.15 Patients who receive chemotherapy and/or radiotherapy generally will experience symptom relief within 1 to 2 weeks. Monitor the patient for relief of symptoms by... 

What happens when you go to your primary-care physician Do you feel that he is engaged with you Does she make frequent eye contact Does he ask enough questions, and does she seem to listen when you answer them Or does he seem impatient and rushed, spending more time looking at a laptop computer than at you The way in which a clinician interacts with her patients can affect the outcome of treatment - and not just of treatment for mental-health problems, but treatment for physical conditions as well.1... 

In acute pain, comorbid conditions are usually not present, and outcomes of treatment are generally predictable. In chronic pain, comorbid conditions are often present, and outcomes of treatment are often unpredictable. 

The desired outcomes of treatment of GAD are to reduce severity, duration, and frequency of the symptoms and to improve overall functioning. The long-term goal is minimal or no anxiety or depressive symptoms, no functional impairment, and improved quality of life. 

Keystone, E. C., Kavanaugh, A. E., Sharp, J. T., et al. (2004) Radiographic, cUnical, and functional outcomes of treatment with adaUmumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy a randomized, placebo-controUed, 52-week trial. Arthritis and Rheumatism. 50, 1400-1411. 

The null hypothesis postulates that there is no difference in outcome between a new and a standard drug. Thus when two groups of patients have been treated separately with the drugs (between-patient comparisons) or when each patient has received both drugs (within-patient comparisons) and the result of the outcome of treatment is apparently better with one drug than the other, it is essential to determine if this difference is statistically significant. 

Neuron-specific enolase (NSE). NSE is useful for monitoring the outcome of treatment and the course of disease in patients with neuroendocrine tumors, in particular small cell lung cancer and neuroblastoma. The test is not suitable as a screening or adjunct to diagnosis because of low clinical sensitivity and specificity. Elevated serum NSE concentrations are found in patients with ... 

Outcome measurements used in the evaluation of the outcome of treatment of RA with sulfasalazine, parenteral gold salts, D-penicillamine, hydroxychloroquine, prednisolone, MTX, cyclophosphamide (CyC), and azathioprine in single drug therapy cannot be compared with endpoints used in SBC-5-lMNs and biological-DMARDs combined with MTX. 

March, J.S., and Curry, J.F. (1998) Predicting the outcome of treatment. / Abnorm Child Psychol 26 39-51. 

Darke S (1998). The effectiveness of methadone maintenance treatment. 3 Moderators of treatment outcome. In Ward J, Mattick RP, Hall W (eds.) Methadone Maintenance Treatment and Other Opioid Replacement Therapies. London Harwood, pp. 75-90 Darke S, Hall W, Wodak A, Heather N Ward J (1992a). Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users the Opiate Treatment Index. British Journal of Addiction, 87, 733-42 Darke S, Hall W, Ross MW Wodak A (1992b). Benzodiazepine use and HIV risk-taking... 

May PRA, Van Putten T, Jenden DJ, et al. Chlorpromazine levels and the outcome of treatment in schizophrenic patients. Arch Gen Psychiatry 1981 38 202-207. 

The conventional proof of efficacy is still the key to product registration and market entry, but in the new, information-intensive environment it brings no competitive advantage. Those responsible for the purchase of pharmaceuticals have begun to demand proof of value, which is to be found in information on the medical and economic outcomes of treatment, and the best means to those ends. Proof of efficacy can usually suffice as proof of value if it applies to the first curative medicine for a hitherto untreatable disease, but hardly so when the choice is among multiple, like-indicated, differently priced agents. 

The effect of fluoroquinolone-resistance in Campylobacter on the clinical outcome of treatment with a fluoroquinolone is not yet clear. There are conflicting data on whether resistant Campylobacter can cause more severe disease. Although there has been little documented impact of this resistance on human health, current concern about the potential human health consequences if resistance were to increase and spread, is high. Tims, further research and data-gathering are essential to quantify this potential. In addition to quinolone resistance, coresistance... 

Bacterial keratitis is one of the most frequent ophthalmic infections. In a meta-analysis of publications from 1950 to 2000, the use of a topical glucocorticoid before the diagnosis of bacterial keratitis significantly predisposed to ulcerative keratitis in eyes with preexisting corneal disease (OR = 2.63 95% Cl = 1.41, 4.91). Previous glucocorticoid use significantly increased the risk of antibiotic failure or other infectious complications (OR = 3.75 95% Cl = 2.52, 5.58). The use of glucocorticoids with an antibiotic for the treatment of bacterial keratitis did not increase the risk of complications, but neither did it improve the outcome of treatment. 

How can a product s formulation affect the outcome of treatment for the condition ... 

What is the goal of therapy and the role of the pharmacist in the management of this condition How do the products generally used to treat the condition work How can a product s formulation affect the outcome of treatment for the condition ... 

Elevated LH levels might cause elevated progesterone levels on the day of hCG administration. Elevated progesterone levels on the day of hCG administration could thus be correlated with adverse outcome of treatment. 

---